Healthcare & Medical Devices Global On demand · 24-48h

Global Safety Blood Collection Needle Market Strategic Research Report

Global Safety Blood Collection Needle Market Strategic Resea…
$3,500 USD
Market Research Reports
Strategic Research Report
Global Safety Blood Collection Needle Market
$1.28B2025
7.4%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Passive Safety Blood Collection Needle, Active Safety Blood Collection Needle

By Application: Hospital, Clinic, Others

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Innovative MedTech, Sol-Millennium, Becton Dickinson, Sarstedt, Terumo, Nipro, Greiner Bio-One, Owen Mumford, Mediplus, KB Medical Group, Husk Medical B.V, GBUK Group, Berpu Medical Technology, Shanghai Kindly Enterprise Development, Maider Medical, Liuyang SANLI Medical Technology Development, Shandong Ande Healthcare Apparatus

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 128 pages
Market size 2025
$1.28B
Billion USD
Forecast CAGR
7.4%
2025-2032
Forecast 2032
$2.1B
Projected
リージョン
5
Asia Pacific · Latin America · MEA · Europe · North America

概観

Scope of the Report

The global Safety Blood Collection Needle market size is predicted to grow from US$ 1,285 million in 2025 to US$ 2,105 million in 2032; it is expected to grow at a CAGR of 7.4% from 2026 to 2032.

Safety Blood Collection Needles are blood collection devices that integrate passive or active protection mechanisms, with their core function being to automatically shield the needle tip through mechanical structures such as spring retraction, sheath sliding, or pressure activation after blood collection. This product aims to fundamentally eliminate the occupational exposure risk of healthcare workers to needlestick injuries and bloodborne pathogens during blood collection procedures. Distinguished from ordinary blood collection needles, safety blood collection needles enter a locked state after needle activation, preventing reuse, while their ultra-thin wall and three-bevel needle tip design significantly reduce patient puncture pain without compromising blood sample quality. Currently, this product has evolved from a simple occupational protection tool into a comprehensive single-use consumable integrating patient comfort experience and in-hospital infection control functions, where its clinical penetration rate directly affects healthcare institutions' occupational safety assessment indicators and patient visit satisfaction.

Market Development Opportunities and Main Drivers

The continuous rise in global chronic disease prevalence, particularly the rigid demand for daily blood collection in diabetes monitoring, has created a huge consumer base for safety blood collection needles. The tightening regulatory environment constitutes the most core driving force, with regulations represented by the US Needlestick Safety and Prevention Act and relevant EU directives mandating the use of engineered safety devices, directly driving the batch elimination of traditional blood collection needles. WHO data shows that global safety device coverage remains uneven, with significant penetration space in developing countries. The popularization of home testing and primary healthcare has gradually made safety blood collection needles with one-button activation and needlestick prevention features the preferred consumable for home blood glucose monitoring.

Market Challenges and Risks

Cost control is the main obstacle to the popularization of safety blood collection needles. Safety devices integrate precision mechanical retraction components, resulting in significantly higher unit manufacturing costs, which creates promotion resistance in emerging markets with tight healthcare budgets, leading some regions to continue using traditional blood collection needles with safety hazards due to cost factors. Core components such as precision injection molds and high-elasticity springs have extremely high processing precision requirements, and production capacity fluctuations may affect delivery stability. The market has numerous brands with high homogeneity in basic models, and price competition continues to compress industry profit margins. Inconsistent quality of existing evidence-based medicine makes it difficult for some healthcare institutions to evaluate the input-output ratio of different safety devices.

Downstream Demand Trends

Healthcare institution procurement decisions are shifting from merely meeting regulatory compliance to improving clinical operation efficiency, with models featuring depth adjustment and one-handed activation being favored by professional nursing staff. The growth rate of out-of-home and home use scenarios is significant, with portable blood collection needles featuring intuitive operation, high needle concealment, and low pain becoming an important growth segment. In intensive care and pediatric fields requiring extremely high infection control, demand for special safety devices that prevent blood splatter and sample contamination is increasing. The expansion of companion diagnostics and point-of-care testing markets has driven supporting procurement of dedicated safety blood collection needles bound to specific testing equipment.

Regional Trends

North America and Europe, leveraging their strict occupational safety regulatory enforcement systems, maintain the most stable replacement demand for safety blood collection needles and are the core markets for global mid-to-high-end brand competition. The Asia-Pacific region, benefiting from a large diabetic patient population, rapid medical infrastructure construction, and awakening middle-class self-health awareness, has become the fastest-growing regional market, with local manufacturers rapidly increasing market share through complete industrial chain support and cost control capabilities.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Safety Blood Collection Needle market?

What factors are driving Safety Blood Collection Needle market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Safety Blood Collection Needle market opportunities vary by end market size?

How does Safety Blood Collection Needle break out by Type, by Application?

This report presents a comprehensive overview of the global Safety Blood Collection Needle market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Passive Safety Blood Collection Needle
  • Active Safety Blood Collection Needle

Segment by Structural Type

  • Butterfly Safety Blood Collection Needle
  • Straight Safety Blood Collection Needle
  • Pen Type Safety Blood Collection Needle

Segment by Needle Tip Design

  • Bevel Safety Blood Collection Needle
  • Pencil-Point Safety Blood Collection Needle
  • Lancet Safety Blood Collection Needle

Segment by Application

  • Hospital
  • Clinic
  • Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Safety Blood Collection Needle market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Hospital, Clinic, Others evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Safety Blood Collection Needle Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 7.4%
Regional growth momentum
Market share by segment
Key metrics
Base value
$1.28B
2025
Forecast
$2.1B
2032
CAGR
7.4%
2025–2032
リージョン
5
global
Key companies
Innovative MedTechSol-MillenniumBecton DickinsonSarstedtTerumoNiproGreiner Bio-OneOwen Mumford
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Passive Safety Blood Collection NeedleActive Safety Blood Collection Needle
By Application
HospitalClinicOthers

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Passive Safety Blood Collection Needle
  • 3.1.3 Active Safety Blood Collection Needle
  • 3.1.4 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Hospital
  • 4.1.3 Clinic
  • 4.1.4 Others
  • 4.1.5 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Innovative MedTech
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Sol-Millennium
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Becton Dickinson
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Sarstedt
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Terumo
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Nipro
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 Greiner Bio-One
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Owen Mumford
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 Mediplus
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 KB Medical Group
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 Husk Medical B.V
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 GBUK Group
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 Berpu Medical Technology
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
  • 8.14 Shanghai Kindly Enterprise Development
  • 8.14.1 Company Overview
  • 8.14.2 Key Products & Segments
  • 8.14.3 Financial Performance (2023–2025)
  • 8.14.4 Business Strategy
  • 8.14.5 SWOT Analysis
  • 8.14.6 Strategic Implications (2026–2032)
  • 8.15 Maider Medical
  • 8.15.1 Company Overview
  • 8.15.2 Key Products & Segments
  • 8.15.3 Financial Performance (2023–2025)
  • 8.15.4 Business Strategy
  • 8.15.5 SWOT Analysis
  • 8.15.6 Strategic Implications (2026–2032)
  • 8.16 Liuyang SANLI Medical Technology Development
  • 8.16.1 Company Overview
  • 8.16.2 Key Products & Segments
  • 8.16.3 Financial Performance (2023–2025)
  • 8.16.4 Business Strategy
  • 8.16.5 SWOT Analysis
  • 8.16.6 Strategic Implications (2026–2032)
  • 8.17 Shandong Ande Healthcare Apparatus
  • 8.17.1 Company Overview
  • 8.17.2 Key Products & Segments
  • 8.17.3 Financial Performance (2023–2025)
  • 8.17.4 Business Strategy
  • 8.17.5 SWOT Analysis
  • 8.17.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

How big is the global Safety Blood Collection Needle market?
The global Safety Blood Collection Needle market is estimated at US$ 1.28 billion in 2025 (base year) and is projected to reach US$ 2.1 billion by 2032.
How fast is the Safety Blood Collection Needle market expected to grow?
The market is expected to grow at a CAGR of 7.4% from 2026 to 2032, expanding from US$ 1.28 billion in 2025 to US$ 2.1 billion in 2032, roughly 1.6 times its base-year value.
What does the Safety Blood Collection Needle market cover?
Safety Blood Collection Needles are blood collection devices that integrate passive or active protection mechanisms, with their core function being to automatically shield the needle tip through mechanical structures such as spring retraction, sheath sliding, or pressure activation after blood collection. This product aims to fundamentally eliminate the occupational exposure risk of healthcare workers to needlestick injuries and bloodborne pathogens during blood collection procedures.
What are the main segments of the Safety Blood Collection Needle market by type?
By type, the market is segmented into Passive Safety Blood Collection Needle and Active Safety Blood Collection Needle.
Which applications drive demand in the Safety Blood Collection Needle market?
Key applications covered include Hospital, Clinic and Others.
Who are the key players in the Safety Blood Collection Needle market?
Key players profiled include Innovative MedTech, Sol-Millennium, Becton Dickinson, Sarstedt, Terumo, Nipro, Greiner Bio-One and Owen Mumford, among 17 companies covered in total.
Which regions and countries are covered for Safety Blood Collection Needle?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What is driving growth in the Safety Blood Collection Needle market?
The tightening regulatory environment constitutes the most core driving force, with regulations represented by the US Needlestick Safety and Prevention Act and relevant EU directives mandating the use of engineered safety devices, directly driving the batch elimination of traditional blood collection needles.
Who should buy the Safety Blood Collection Needle market report?
The report is intended for manufacturers and solution providers, distributors and end users in Hospital, Clinic and Others, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Safety Blood Collection Needle market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from $3,500.00
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.